AFT Pharmaceuticals Ltd

Chart & Performance

D1W1MN

P/E

28.05

P/S

1.63

EPS

0.11

Div Yield, %

1.00%

Shrs. gr., 5y

1.51%

Rev. gr., 5y

14.32%

Revenues

205m

+5.16%

Net income

12m

-23.36%

CFO

13m

-48.43%

Dividend

Jun 19, 20240.016 NZD/sh

Notes

No notes on this company yet

Write a private note on this company, for your eyes only

Add note

Profile

AFT Pharmaceuticals Limited develops, licenses, distributes, and sells pharmaceutical products in New Zealand, Australia, Asia, and internationally. It offers products for use in the areas of allergy, cold and flu, eyecare, first aid, pain management, gastrointestinal, dermatology, and medicated vitamins. The company was incorporated in 1997 and is headquartered in Auckland, New Zealand.

URL

http://www.aftpharm.com/

IPO date

Dec 22, 2015

Employees

100

Domiciled in

Incorporated in

Valuation

Order:

Title NZD in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY	FY	FY
Title NZD in thousands, except ratios and share amounts	2025‑03	2024‑03	2023‑03	2022‑03	2021‑03	2020‑03	2019‑03	2018‑03	2017‑03	2016‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT